WuXi AppTec (OTCMKTS:WUXAY) Sets New 52-Week High – Still a Buy?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) reached a new 52-week high during trading on Thursday . The company traded as high as $18.59 and last traded at $18.59, with a volume of 206 shares. The stock had previously closed at $17.91.

Analyst Ratings Changes

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

WuXi AppTec Price Performance

The firm’s fifty day simple moving average is $16.56 and its 200-day simple moving average is $15.14.

WuXi AppTec (OTCMKTS:WUXAY) last issued its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.05. The company had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.